What is Zumenon®?
Zumenon® is indicated for estrogen deficiency symptoms in postmenopausal women at least 6 months since last menses.
Why 17β estradiol?
- Body-identical 17β estradiol
Indications of Zumenon®
Zumenon® is an estrogen only continuous HRT for women with or without a uterus. In general, treatment should start with Zumenon® 1mg. Depending on the clinical response, the dosage can afterwards be adjusted to individual need. If the woman still has estrogen deficiency symptoms the dosage can be increased by using Zumenon® 2mg.1
|Regime||Dose||Bone protection||Pack||Price (£)2|
These products are additionally licensed for the prevention of osteoporosis in post-menopausal women at high risk of the future fractures who are intolerant of, or contraindicated for, other medical products.
Add a progestogen if used in women with a uterus. This could be a separately prescribed therapy such as a 52mg intrauterine delivery system with a license for endometrial protection or micronised progesterone. You may also consider a combined HRT preparation such as Femoston® or Femoston®-conti (estradiol + dydrogesterone).
Benefits of oral estradiol therapy
The active ingredient, 17β-estradiol is a regulated bioidentical hormone (or body identical hormone) and is similar to its biological equivalent.3 It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms.
- Relief of estrogen-deficiency symptoms1
- Relief of menopausal symptoms was achieved during the first few weeks of treatment1
- Hot flushes have been shown to be significantly reduced with 1 mg and 2 mg 17β-estradiol at 4 weeks1